Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04DBA
|
|||
| Former ID |
DNC002336
|
|||
| Drug Name |
BAG956
|
|||
| Synonyms |
NVP-BAG956; 853910-02-8; BAG 956; NVP-BAG956(BAG 956); BAG-956; UNII-4UFC2K6E50; 4UFC2K6E50; 2-Methyl-2-(4-(2-methyl-8-((pyridin-3-yl)ethynyl)imidazo(4,5-C)quinolin-1-yl)phenyl)propionitrile; 2-methyl-2-(4-(2-methyl-8-(pyridin-3-ylethynyl)-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile; BAG956; 2-Methyl-2-{4-[2-methyl-8-(pyridin-3-ylethynyl)-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile; 2-Methyl-2-[4-[2-methyl-8-[(pyridin-3-yl)ethynyl]imidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile; NVP-BAG-956
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Haematological malignancy [ICD-11: 2B33.Y] | Investigative | [1] | |
| Therapeutic Class |
Anticancer Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H21N5
|
|||
| Canonical SMILES |
CC1=NC2=CN=C3C=CC(=CC3=C2N1C4=CC=C(C=C4)C(C)(C)C#N)C#CC5=CN=CC=C5
|
|||
| InChI |
1S/C28H21N5/c1-19-32-26-17-31-25-13-8-20(6-7-21-5-4-14-30-16-21)15-24(25)27(26)33(19)23-11-9-22(10-12-23)28(2,3)18-29/h4-5,8-17H,1-3H3
|
|||
| InChIKey |
GVPAGJWVBUZHNQ-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 853910-02-8
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
50138328, 57455878, 125267722, 135698907, 136368062, 137275931, 144115680, 152258546, 152344017, 160647380, 160778541, 162011843, 163124231, 163685644, 172650452, 174530995, 185970705, 188941732, 198961161, 204380019, 208265325, 223704856, 231421751, 241376546, 242554121, 247462095, 251963185, 252157396, 252160021, 252215930, 252439853, 252552917
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The PI3K/Akt pathway as a target in the treatment of hematologic malignancies. Anticancer Agents Med Chem. 2009 Jun;9(5):550-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.